Oregon releases plan to reduce the burden of cancer statewide
Plan developed by OHSU, OHA offers five areas of focus: liver, breast, colorectal and lung cancers, boosting HPV vaccination rates.
- Latest Stories
- Popular
OHSU-led panel: Exercise is essential for seniors in cancer treatment, who are cancer survivors
February 19, 2026
OHSU mourns the passing of Avel Gordly
February 19, 2026
Study reveals low rates of routine screening for anxiety, intimate partner violence in Oregon
February 18, 2026
OHSU-led research initiative examines supervised psilocybin
February 12, 2026
Accolades: Awards, honors and appointments February
February 17, 2026
Study highlights impact of infection prevention measures in NICU
February 12, 2026
Featured Multimedia
States with abortion restrictions have worse outcomes for patients using fertility treatment
OHSU study highlights continued far-reaching implications of abortion restrictions on reproductive health care.
OHSU researchers find breast cancer drug boosts leukemia treatment
Scientists identified a new drug combination that could overcome treatment resistance in acute myeloid leukemia.
OHSU research drives FDA approval for novel use of anemia drug in brain cancer imaging
OHSU lab started exploring new use of the drug 30 years ago; now, it may improve techniques to measure, monitor aggressive brain tumors.
Researchers identify kidney sensor that helps control fluid balance
Study findings reveal how the kidney detects changes in blood volume, may guide future research on kidney diseases.
Mixed results in using lipoic acid to treat progressive multiple sclerosis
OHSU-led randomized controlled trial examines benefits of over-the-counter antioxidant.
Study: Dangerous E. coli strain blocks gut’s defense mechanism to spread infection
Research from OHSU sheds light on why some bacteria aren’t easily shed by the body.
OHSU awarded $6.7 million to study effects of cannabis use during pregnancy in people with HIV
Study will explore impact of THC use on maternal, placental, fetal health in context of HIV infection.
Over-the-counter pill boosts access to contraception, OHSU study finds
Nationwide study documents 31% percentage point increase in people shifting from no birth control to the over-the-counter oral contraceptive.
OHSU research team lands federal funding to study aggressive head and neck cancer
$3.5 million award from the National Institutes of Health will fund organ-on-a-chip model of oral cancer and bone invasion.
Review suggests ending adult boosters for tetanus, diphtheria
As long as childhood vaccination rates remain strong, U.S. could save $1 billion annually by dropping boosters for adults.
$2.1 million gift enhances OHSU center’s efforts to combat diabetes
Real estate developer and philanthropist Jordan Schnitzer provides gift to center previously established by his parents.
OHSU honors 2025 graduates
Nearly 1,200 degrees, certificates to be awarded during commencement ceremony today.
